Follow Us: social media social media social media    Language :           

Reaksi Drug Safety News 2017 - Issue 5/2017

Reaksi Drug Safety News 2017,

Issue 5/2017

 

  • Vemurafenib: Risk of Dupuytren’s Contracture and Plantar Fascial Fibromatosis
  • Leflunomide and Teriflunomide: Risk of Falsely Decreased Ionised Calcium Levels and Risk of Colitis

 



 
 
  DOWNLOAD PDF


 

 

 

qrcode